Quantori
Quantori is a Cambridge, MA-based software and digital services firm that builds AI-enabled solutions (Q-Suite platform) for life sciences and healthcare R&D, serving 12 of the 15 largest pharmaceutical companies plus biotech, instruments, and research clients globally.
- Company typePrivate
- Founded2020
- HeadquartersCambridge, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingSoftware
What Quantori does
Quantori is a private, Cambridge, Massachusetts-headquartered software and digital services firm that builds AI-enabled solutions for life sciences and healthcare R&D. The company employs 750+ data scientists, data engineers, and domain experts (with more than 15% holding MDs or PhDs) and serves 12 of the 15 largest global pharmaceutical companies alongside 20+ mid-market and startup biotech clients, including Pfizer, AstraZeneca, Eli Lilly, Novartis, Bristol Myers Squibb, Takeda, Biogen, Genentech, Gilead, Syngenta, BioNTech, Bruker, PerkinElmer, LGC, and JAX.
The company's flagship product is Q-Suite, a modular agentic AI platform consisting of Q-Scientist (enterprise AI and data platform for multi-omics and LLM-powered analysis), Q-Models (ADMET prediction ML suite, co-developed with Expert Systems), Q-Portal (governed LLM deployment for regulated environments), Q-Discover (agentic drug discovery and computational chemistry), Q-HPC (computational infrastructure orchestration), Q-Data (unified life sciences data foundation), and Q-Image (4D medical imaging analytics). The platform integrates with on-prem, cloud, and hybrid environments and supports multimodal AI across text, imaging, and structured scientific data.
Quantori monetizes through a hybrid model: professional services and consulting (digital transformation, data engineering, scientific informatics, cloud engineering) and subscription/recurring revenue from Q-Suite platform products. Distribution is enterprise-direct via a 'Schedule Consultation' sales motion, complemented by AWS Advanced Services, Azure, GCP, Databricks, Snowflake, and Atlassian partnerships, AWS Marketplace listing, and a multi-channel marketing program including proprietary roundtables, industry conferences, and scientific content. The company is backed by a $15 million Flint Capital investment (October 2022) at a $100 million post-money valuation and holds ISO 27001 and AICPA SOC certifications.
Quantori firmographics
Firmographics- Name
- Quantori
- Legal name
- Quantori, LLC
- Website
- https://quantori.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Quantori is a Cambridge, MA-based software and digital services firm that builds AI-enabled solutions (Q-Suite platform) for life sciences and healthcare R&D, serving 12 of the 15 largest pharmaceutical companies plus biotech, instruments, and research clients globally.
- Ownership category
- akta.pro rank
Quantori industry classification
Industry- Product category
- Life Sciences R&D Software & Digital Services
- NAICS
- Custom Computer Programming Services (541511), Software Publishers (513210), Computer Systems Design Services (541512)
- SIC
- Services-Computer Programming Services (7371), Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)
- akta.pro secondary industries
- AI/ML Engineering & Model Development Services (BPAEAHAF), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA), Enterprise Foundation Model Integration & APIs (Connectors, Governance, Deployment) (HDAAACAO)
Keywords
Where Quantori is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Quantori business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Digital Services and Consulting: End-to-end digital transformation and AI-driven solutions for life sciences and healthcare companies. Professional services including software engineering, scientific informatics, data science, and cloud engineering.
- Q-Suite Platform Products: AI-enabled platform products and accelerators (Q-Scientist, Q-Discover, Q-Models, Q-HPC, Q-Portal, Q-Data, Q-Image) delivered as enterprise software solutions.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
Quantori product offering
Product offeringCore offering
Quantori builds and sells the Q-Suite modular agentic AI platform for life sciences R&D, comprising Q-Scientist, Q-Models, Q-Portal, Q-Discover, Q-HPC, Q-Data, and Q-Image, alongside complementary digital IT, scientific informatics, data science, cloud engineering, and software development services for pharmaceutical, biotechnology, and healthcare customers.
Product overview
Quantori offers Q-Suite, a modular agentic AI platform for life sciences R&D, consisting of core flagship accelerators (Q-Scientist, Q-Models, Q-Portal) plus additional specialized modules (Q-Discover, Q-HPC, Q-Data, Q-Image). The platform combines deep domain expertise with advanced engineering to build AI-enabled digital solutions for healthcare and life sciences. Q-Scientist serves as the enterprise AI and data platform, Q-Models provides ADMET prediction ML models, and Q-Portal governs LLM usage in regulated environments. Additional modules include Q-Discover for drug discovery workflows, Q-HPC for computational infrastructure optimization, Q-Data for unified data foundations, and Q-Image for medical imaging analysis. Quantori also offers standalone API products like the ML Conformer Generator and Deck.AI enterprise knowledge management tool.
Differentiator
Problem solved
Functional benefit
Products and services
- Q-Scientist Enterprise-grade AI and data platform that lets scientific teams run advanced R&D workflows, from multi-omics to LLM-powered analysis, through a modular interface with secure integration into existing on-prem, cloud, or hybrid infrastructure.
- Q-Models Comprehensive suite of machine learning models for predicting absorption, distribution, metabolism, excretion, and toxicity (ADMET) in drug discovery, delivered as a core service within the modular Q-Suite architecture.
- Q-Portal Enterprise-ready platform for securely introducing and managing Large Language Model capabilities across pharmaceutical and healthcare organizations, providing a governed, compliance-aware environment for Generative AI with sensitive data.
- Q-Discover End-to-end agentic AI platform that accelerates and streamlines the drug discovery and computational chemistry pipeline, integrating AI/ML molecular design, high-performance computing, and multi-agent workflow orchestration.
- Q-HPC Agentic platform that automatically manages, optimizes, and scales computational infrastructure required for demanding scientific research, replacing manual resource allocation with intelligent, unified systems.
- Q-Data Enterprise-grade data platform that transforms fragmented life sciences data into a unified, AI-ready foundation for accelerated discovery, with intelligent automation that eliminates data preparation bottlenecks.
- Q-Image Unified AI-powered platform that transforms medical imaging from static moments into interactive 4-dimensional (3D space + Time) longitudinal models, integrating images from disparate sensors and sources.
- ML Conformer Generator API Inference Server Advanced API-based solution designed to accelerate small molecule discovery through 3D shape-constrained generation of molecular conformers.
- Deck.AI Enterprise-level knowledge management tool designed to streamline the process of creating and managing presentations for life sciences and healthcare organizations.
- Digital Services and Consulting End-to-end digital transformation and AI-driven professional services for life sciences and healthcare customers, including software engineering, scientific informatics, data science, cloud engineering, and DevOps.
Quantifiable outcome
- Serving 12 of 15 largest pharmaceutical companies globally
- +3 more outcomes
Companies that use Quantori
Customer profileNamed customers26 records
Segments4 records
Ideal customer profiles4 records
Quantori technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability12 records
Feature9 records
Quantori partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core, minor and notable.
- Decoy TherapeuticscoreStrategic partnership to deploy Google Cloud-native integrated AI-driven peptide design and molecular simulation platform. The platform integrates advanced protein folding models, molecular dynamics simulations, and AI into Decoy's proprietary IMP3ACT design engine. Expected to increase computational throughput by 25- to 100-fold.
- Expert SystemscoreStrategic partnership to develop and integrate foundational predictive AI models for pharmaceutical research and development. Collaboration aims to improve drug discovery processes by forecasting outcomes and accelerating workflows, potentially reducing development time and costs.
- Knowledge3minorCo-marketing partnership to advance knowledge-driven AI in life sciences. Together, Quantori and Knowledge3 aim to help organizations move beyond fragmented data environments and siloed AI initiatives.
- Google CloudcoreCloud platform partner providing infrastructure for AI-driven solutions. Google Cloud funding supports partnerships like the Decoy Therapeutics collaboration. Quantori is recognized as having deep GCP expertise.
- Amazon Web Services (AWS)coreAWS Advanced Services Partner with over 20 years of superior software engineering skills combined with AWS technologies. Team of AWS-certified engineers with special expertise in healthcare and life sciences. Achieved 50 AWS certifications milestone.
- Microsoft AzurecoreCloud platform partner offering Azure-based digital transformation and cloud consulting services for life sciences and healthcare organizations.
- ImmuVianotableImmuVia selected Quantori's Q-Scientist platform to streamline computational workflows across its preclinical programs for first-in-class cancer therapy development.
- DatabricksnotableTechnology partnership for data analytics and AI platform integration, enabling scalable data lakehouse architectures for life sciences customers.
- NebiusnotableTechnology partnership with cloud GPU provider for molecular generation and AI model training. Joint EDM (Equivariant Diffusion Models) research initiative for 3D molecule generation using Nebius cloud H200 Nvidia GPUs.
- SnowflakenotableTechnology partnership for cloud data platform integration, enabling seamless data management and analytics capabilities for life sciences organizations.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Quantori competitors and assessment
Company assessmentDirect peers
- EPAM Systems: EPAM Systems is the most directly comparable peer: a large IT services and digital transformation firm with a substantial life sciences practice. Quantori's CEO Richard Golob was previously Global Head of Life Sciences at EPAM, and the CTO/CSO co-founded GGA Software Services which EPAM acquired in 2014. Direct overlap in pharma R&D informatics, data engineering, and digital services.
- Axtria: Axtria is a cloud software and data analytics company purpose-built for life sciences, providing commercial, sales, and R&D analytics platforms and services. Directly comparable in vertical focus on pharma and the combination of proprietary cloud platforms (Axtria DataMAx, Axtria SalesIQ) with implementation services.
- Saama Technologies: Saama is a life sciences-focused AI and data analytics company serving biopharma with clinical and commercial data platforms. Comparable to Quantori in vertical specialization in pharma and in combining AI/ML engineering services with proprietary platform offerings (Saama Life Science Analytics Cloud).
- ZS Associates: ZS is a management consulting and technology firm dedicated to life sciences, offering analytics, AI, and software solutions to pharma clients. Comparable to Quantori's life sciences-only focus, data science depth, and mix of consulting plus proprietary software (ZS Discovery, ZS Affinity).
Emerging players
- Benchling: Benchling is a cloud-native life sciences R&D platform serving biotech and pharma with lab notebook, molecular biology, and biologics workflow software. Comparable to Quantori's Q-Suite platform ambition for R&D informatics, though Benchling focuses on SaaS lab execution while Quantori emphasizes AI/data analytics and services.
- Schrödinger: Schrödinger provides computational chemistry and molecular simulation software (LiveDesign) for drug discovery, used by major pharma companies. Overlaps with Quantori's Q-Discover molecular design capabilities and the broader push into AI-driven drug discovery, though Schrödinger is more product-pure and own-pipeline-heavy.
- Insilico Medicine: Insilico Medicine applies generative AI to drug discovery and has internal pipeline plus pharma partnerships. Comparable to Quantori's generative AI / molecular design work in Q-Discover, though Insilico is more product-pipeline focused and a customer/partner rather than a direct services competitor.
Broad incumbents
- Accenture Life Sciences: Accenture operates a global Life Sciences practice delivering digital strategy, cloud, data/AI, and R&D informatics services to the largest pharma companies. Larger, broader portfolio competitor with similar GTM motion targeting enterprise pharma, but not life sciences-specialized like Quantori.
- Cognizant: Cognizant is a global IT services giant with a dedicated Life Sciences business unit offering digital transformation, clinical operations, and R&D informatics services. Broad incumbent overlap with Quantori's service offerings, though Cognizant serves many verticals and is not life sciences-specialized.
- Tata Consultancy Services (TCS): TCS is a global IT services firm with a dedicated Life Sciences & Healthcare practice offering R&D informatics, clinical data management, and digital transformation. Comparable on enterprise pharma delivery and AI/ML services scale, though much broader than Quantori's vertical focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Quantori social profiles
Digital presenceQuantori compliance and trust
Trust signalCompliance2 records
Quantori financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quantori leadership team
Management profileNumber of profiles
Profiles9 records
Quantori funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quantori M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quantori
What does Quantori do?
Quantori builds and sells the Q-Suite modular agentic AI platform for life sciences R&D, comprising Q-Scientist, Q-Models, Q-Portal, Q-Discover, Q-HPC, Q-Data, and Q-Image, alongside complementary digital IT, scientific informatics, data science, cloud engineering, and software development services for pharmaceutical, biotechnology, and healthcare customers.
Is Quantori a public or private company?
Quantori is a private company. It is classified as venture growth investor backed and is currently operating.
When was Quantori founded?
Quantori was founded in 2020. It employs 501 to 1,000 people.
Where is Quantori based?
Quantori is headquartered in Cambridge, United States, in the North America region.
How does Quantori make money?
Two revenue lines are on record. Digital Services and Consulting is the primary driver. The others are Q-Suite Platform Products.
Who are Quantori's main competitors?
Direct peers on record are EPAM Systems, Axtria, Saama Technologies and ZS Associates. Emerging players are Benchling, Schrödinger and Insilico Medicine. Broad incumbents are Accenture Life Sciences, Cognizant and Tata Consultancy Services (TCS).
Does Quantori have an API?
Yes. Quantori offers the ML Conformer Generator API Inference Server, an advanced API-based solution designed to accelerate small molecule discovery through 3D shape-constrained generation. Additionally, the company provides API Gateway services for developing, maintaining, and publishing APIs, including deployment, monitoring, traffic management, and access control for processing concurrent API calls.
What industry is Quantori in?
Quantori's product category is Life Sciences R&D Software & Digital Services. Its primary akta.pro industry code is HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs), with a secondary code of BPAEAHAF, AI/ML Engineering & Model Development Services. Its NAICS code is 541511 and its SIC code is 7371.